Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Board/Management Information 2023

Nov 14, 2023

61842_rns_2023-11-14_f5dd7f3f-91c5-4f60-b4a6-2874f1e612ea.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in

November 14, 2023

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540 Scrip Code: SOLARA

Dear Sirs,

  • Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) – Appointment of Directors

Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you based on the recommendations of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today, (November 14, 2023), appointed Mr. Rajendra Kumar Srivastava (DIN: 07500741) as Additional Non-Executive Independent Director and Mr. Rajiv Vijay Nabar (DIN: 10383397) as Additional Non-Executive Non-Independent Director of the Company, subject to approval of the shareholders. The required details pursuant to SEBI Listing Regulations are annexed herewith as Annexure – I.

We hereby confirm that Mr. Rajendra Kumar Srivastava satisfies the criteria of independence prescribed under the Companies Act, 2013 and SEBI Listing Regulations.

We also confirm that they are not debarred from holding the office of Director by virtue of any order passed by SEBI or any other such authority.

We request you to take the same on record.

Thanking you,

Yours faithfully, For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2023.11.14 15:45:06 +05'30'

S. Murali Krishna Company Secretary

Encl.: As above

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

ANNEXURE 1

Name of Director Rajendra Kumar Srivastava (DIN: 07500741)
Reason for change viz.
appointment, re-appointment,
resignation, removal, death or
otherwise
Mr. Rajendra Kumar Srivastava is appointed as an
Additional Non-Executive Independent Director with effect
from November 14, 2023 subject to approval of the
shareholders of the Company
Date of Appointment / ~~R~~~~e-~~
~~appointment/Cessation~~
November 14, 2023
~~appoe~~
Term of appointment 5 years i.e., November 14, 2023, to November 13, 2028
Brief profile Mr. Rajendra Srivastava is the Novartis Professor of
Marketing Strategy and Innovation at the Indian School of
Business (ISB) (Hyderabad & Mohali). He has served Dean
at ISB and is Executive Director for ISB’s Centre for
Business Innovation and Executive Fellows Program in
Management. He has also served as Provost and Deputy
President at Singapore Management University and as
Senior Associate Dean at both Emory University and The
University of Texas at Austin. He is an independent director
on the board of Happiest Minds Technologies, a listed
company.
A pracademic (practical academic) at heart, he is a strong
proponent for inter-disciplinary research and collaboration
between industry, government, and academia. His academic
leadership and contributions to the field of Marketing
focusing on brand equity, marketing-finance interface and
market-based intangible assets have been recognized by
American Marketing Association which appointed him as a
2020 AMA Fellow. He is a member of the EQUIS
Committee of the European Foundation for Management
Development (EFMD). He is also a Senior Research Fellow
at the Mack Institute for Innovation (Wharton), and the
Institute for Studies in Business Markets (ISBM) at Penn
State.
Disclosure of relationship
between directors
Mr. Rajendra Kumar Srivastava is not related to any Director
of the Company.
Other Directorships /
Memberships (in listed entities
in case of resignation of
Independent director)
Not Applicable

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

Name of Director Mr. Rajiv Vijay Nabar (DIN: 10383397)
Reason for change viz.
appointment, re-appointment,
resignation, removal, death or
otherwise
Mr. Rajiv Vijay Nabar is appointed as an Additional Non-
Executive Non-Independent Director with effect from
November 14, 2023 subject to approval of the shareholders
of the Company
Date of Appointment / ~~R~~~~e-~~
~~appointment/Cessation~~
November 14, 2023
~~appoe~~
Term of appointment Not Applicable
Brief profile Mr. Rajiv Vijay Nabar has served as the Principal Chief
Commissioner of Income Tax and has been a distinguished
member of the Indian Revenue Service since 1986. With
over 35 years of experience, he possesses expertise in Direct
Taxes,
International
Taxation,
Investigations,
and
Exemptions. He also served as the Member Secretary of the
CBDT Committee for Speculative Transactions.
During his tenure at SEBI from 1992 to 1997, where he
served as a Division Chief in its formative years, he achieved
significant accomplishments. These include developing the
Stock Watch System, playing a pivotal role in the creation of
the Depositories Act, and setting up procedures in the
Investigation arm. He presided as the Chairman of the SEBI
Committee for Cash Flow Statement standards and Listing
Agreement. He also served on the Boards of several stock
exchanges.
Rajiv holds a Gold Medal in B.Sc. (Hons) from the
University of Delhi. He earned an M.A in Social Work from
DSSW and holds a Diploma in Industrial Relations and
Personnel Management from Bhartiya Vidya Bhavan, Delhi.
Disclosure of relationship
between directors
Mr. Rajiv Vijay Nabar is not related to any Director of the
Company.
Other Directorships /
Memberships (in listed entities
in case of resignation of
Independent director)
Not Applicable

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942